YCBD vs CRON
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
YCBD
CRON
Investment Advisor Scores
CRON
AI Analyst Insights
Detailed Metrics Comparison
| Metric | YCBD | CRON | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 714.2857 | 28.7356 | CRON |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 20.6% | 58.4% | CRON |
| Earnings Growth | 0.0% | 126.8% | CRON |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 57.8/100 | 58.7/100 | CRON |
| Profit Margin | -13.8% | 39.1% | CRON |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG BUY | HOLD | YCBD |
Relative Price Performance (Last 90 Days)
Current Technical Phase
YCBD
MarkdownPrice below a falling SMA50 (slope -12.1%), weak momentum, RSI 37
CRON
MarkupPrice above SMA50, rising 50-day trend (4.8% over 20 days), RSI 56
Fundamentals Snapshot
| Metric | YCBD | CRON |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -1.9 | 13.1 |
| Trailing P/E | 1.6 | 18.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.6% |
| Gross Margin | 0.6% | 0.4% |
| Operating Margin | -0.2% | 0.2% |
| EPS | 0.23 | 0.19 |
| Dividend Yield | — | — |